Valuation: JW Pharmaceutical Corporation

Market Cap 526B 394M 353M 325M 294M 550M 37.42B 560M 3.87B 1.55B 19.69B 1.48B 1.45B 62.08B P/E 2024
9.21x
P/E 2025 10.2x
Enterprise Value 519B 389M 348M 321M 290M 543M 36.95B 553M 3.82B 1.53B 19.43B 1.46B 1.43B 61.29B EV / Sales 2024
0.86x
EV / Sales 2025 0.75x
Free-Float
53.61%
Yield 2024
1.88%
Yield 2025 2.55%
1 day-0.65%
1 week-3.77%
1 month-13.37%
3 months-2.13%
6 months-26.28%
Current year-9.80%
1 week 22,700
Extreme 22700
23,800
1 month 22,700
Extreme 22700
28,100
Current year 21,550
Extreme 21550
39,250
1 year 21,550
Extreme 21550
39,250
3 years 19,600
Extreme 19600
39,250
5 years 15,943.27
Extreme 15943.270512
51,470.59
10 years 15,943.27
Extreme 15943.270512
51,470.59
Manager TitleAgeSince
Chief Executive Officer 63 2025-11-30
Chief Executive Officer 63 -
Corporate Officer/Principal 49 2026-03-25
Director TitleAgeSince
Chairman 63 -
Director/Board Member 63 -
Director/Board Member 63 2025-03-25
Date Insider Type Main position Quantity % Market Cap. Importance
1/7/25 Others 188 0.0008% -
12/9/24 Free 1,107 0.0048% -
2/7/24 Free

Chairman

2,787 0.0120%
Change 5-day change 1-year change 3-year change Capi.($)
-0.65%-3.77%-2.13%-10.46% 394M
+3.19%+11.31%+64.28%+155.91% 1,263B
-0.73%+3.56%+44.65%+84.17% 658B
+1.41%+3.24%+35.25%+108.88% 521B
+0.42%+3.20%+55.81%+72.50% 391B
+2.18%+2.93%+73.90%+45.59% 369B
+1.12%+4.52%+34.76%+58.24% 307B
+6.96%+8.86%+11.95%+36.20% 290B
+1.15%+6.09%+56.15%+82.25% 252B
+3.06%+9.38%+42.48%+117.32% 212B
Average +1.81%+5.27%+41.71%+75.06% 426.23B
Weighted average by Cap. +2.01%+6.60%+50.50%+100.43%

Financials

2024 2025
Net sales 719B 539M 483M 444M 403M 753M 51.21B 767M 5.3B 2.13B 26.94B 2.02B 1.98B 84.96B 775B 581M 521M 479M 434M 811M 55.19B 826M 5.71B 2.29B 29.03B 2.18B 2.14B 91.56B
Net income 65.04B 48.76M 43.67M 40.17M 36.4M 68.04M 4.63B 69.31M 479M 192M 2.44B 183M 179M 7.68B 61.51B 46.12M 41.3M 37.99M 34.42M 64.35M 4.38B 65.55M 453M 182M 2.3B 173M 169M 7.26B
Net Debt 59.18B 44.37M 39.73M 36.55M 33.12M 61.9M 4.21B 63.06M 436M 175M 2.22B 167M 163M 6.99B -6.71B -5.03M -4.5M -4.14M -3.75M -7.02M -477M -7.15M -49.39M -19.83M -251M -18.87M -18.47M -792M
Projected Income Statement - Annual - JW Pharmaceutical Corporation
Logo JW Pharmaceutical Corporation
JW Pharmaceutical Corp is a Korea-based company engaged in the development and manufacturing of pharmaceuticals. The Company mainly produces and sells pharmaceuticals such as blood hyperlipidemia treatment drugs, blood protein amino acid supply drugs, blood and body fluid substitutes, hemophilia treatment drugs, electrolyte additives, rheumatoid arthritis treatment drugs, hepatic coma treatment drugs, perfusion solutions, and iron injections. The Company also researches and develops anticancer drugs.
Employees
1,049
Date Price Change Volume
26-10-30 ₩23,000.00 -0.65% 28,039
26-10-29 ₩23,150.00 -0.22% 32,116
26-10-28 ₩23,200.00 +0.22% 41,883
26-10-27 ₩23,150.00 +0.22% 25,441
26-10-26 ₩23,100.00 -3.35% 27,089
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
MarketScreener Ratings - JW Pharmaceutical Corporation

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - JW Pharmaceutical Corporation
  1. Stock Market
  2. Stocks
  3. A001060 Stock